Evidence map›Paper›PMID 24533985›Full record

Trial reportNuclear medicine and biology2014

Quantification of dopamine transporter density with [18F]FECNT PET in healthy humans.

Jonathon A Nye, John R Votaw, J Douglas Bremner, Margaret R Davis, Ronald J Voll, Vernon M Camp, Mark M Goodman

Open access · greenAbstract readClinical Trial
In one paragraph

Trial report in Nuclear medicine and biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Synthesis and Biological Evaluation of [Molecular imaging and biology · 2021
    Article
  5. Pharmacokinetic evaluation of [European journal of nuclear medicine and molecular imaging · 2020
    Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jonathon A NyeDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, GA 30329. Electronic address: jnye@emory.edu.
John R VotawDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, GA 30329; Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA 30322.
J Douglas BremnerDepartment of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA 30322.
Margaret R DavisDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, GA 30329.
Ronald J VollDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, GA 30329.
Vernon M CampDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, GA 30329.
Mark M GoodmanDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, GA 30329.
Emory University · US

Funding

Neural Circuits in Women with Abuse and PTSDR01MH056120 · NIMH · YALE UNIVERSITY · PI BREMNER, JAMES DOUGLAS · 1999 to 2011
$5.0M
Mechanisms of Depression in CVDR01HL088726 · NHLBI · EMORY UNIVERSITY · PI BREMNER, JAMES DOUGLAS · 2008 to 2012
$2.6M
Biological Correlates of Traumatic StressK24MH076955 · NIMH · EMORY UNIVERSITY · PI BREMNER, JAMES DOUGLAS · 2006 to 2013
$946k
Training Program in Neuroimaging SciencesT32MH067547 · NIMH · EMORY UNIVERSITY · PI BREMNER, JAMES DOUGLAS · 2005 to 2009
$502k
Shared Instrumentation for Research PET Brain DeviceS10RR016917 · NCRR · EMORY UNIVERSITY · PI BREMNER, JAMES DOUGLAS · 2002 to 2002
$500k
Benzodiazepine Receptor in PTSDR21MH080208 · NIMH · EMORY UNIVERSITY · PI BREMNER, JAMES DOUGLAS · 2007 to 2008
$379k
NCRR NIH HHS S10 RR016917NHLBI NIH HHS R01 HL088726NIMH NIH HHS K24 MH076955NIMH NIH HHS R01 MH056120NIMH NIH HHS R21 MH080208NIMH NIH HHS T32 MH067547
6 · The paper itself

Abstract

introductionFluorine-18 labeled 2β-carbomethoxy-3β-(4-chlorophenyl)-8-(2-fluoroethyl)nortropane ([(18)F]FECNT) binds reversibly to the dopamine transporter (DAT) with high selectivity. [(18)F]FECNT has been used extensively in the quantification of DAT occupancy in non-human primate brain and can distinguish between Parkinson's and healthy controls in humans. The purpose of this work was to develop a compartment model to characterize the kinetics of [(18)F]FECNT for quantification of DAT density in healthy human brain.

methodsTwelve healthy volunteers underwent 180 min dynamic [(18)F]FECNT PET imaging including sampling of arterial blood. Regional time-activity curves were extracted from the caudate, putamen and midbrain including a reference region placed in the cerebellum. Binding potential, BPND, was calculated for all regions using kinetic parameters estimated from compartmental and Logan graphical model fits to the time-activity data. Simulations were performed to determine whether the compartment model could reliably fit time-activity data over a range of BPND values.

resultsThe kinetics of [(18)F]FECNT were well-described by the reversible 2-tissue arterial input and full reference tissue compartment models. Calculated binding potentials in the caudate, putamen and midbrain were in good agreement between the arterial input model, reference tissue model and the Logan graphical model. The distribution volume in the cerebellum did not reach a plateau over the duration of the study, which may be a result of non-specific binding in the cerebellum. Simulations that included non-specific binding show that the reference and arterial input models are able to estimate BPND for DAT densities well below that observed in normal volunteers.

conclusionThe kinetics of [(18)F]FECNT in human brain are well-described by arterial input and reference tissue compartment models. Measured and simulated data show that BPND calculated with reference tissue model is proportional to BPND calculated from the arterial input model.

Indexed as

Healthy VolunteersNortropanesAdultDopamine Plasma Membrane Transport ProteinsFemaleHumansImage Processing, Computer-AssistedMaleModels, BiologicalPositron-Emission Tomography2-carbomethoxy-3-(4-chlorophenyl)-8-(2-fluoroethyl)nortropaneDopamine Plasma Membrane Transport ProteinsNortropanesDATDopamine transporterFECNTKinetic modelingPositron emission tomography

Identifiers

PMID24533985
PMCPMC4657438
OpenAlexW1966686110

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.